» Articles » PMID: 25948274

Endogenous Opioid Activity in the Anterior Cingulate Cortex is Required for Relief of Pain

Overview
Journal J Neurosci
Specialty Neurology
Date 2015 May 8
PMID 25948274
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Pain is aversive, and its relief elicits reward mediated by dopaminergic signaling in the nucleus accumbens (NAc), a part of the mesolimbic reward motivation pathway. How the reward pathway is engaged by pain-relieving treatments is not known. Endogenous opioid signaling in the anterior cingulate cortex (ACC), an area encoding pain aversiveness, contributes to pain modulation. We examined whether endogenous ACC opioid neurotransmission is required for relief of pain and subsequent downstream activation of NAc dopamine signaling. Conditioned place preference (CPP) and in vivo microdialysis were used to assess negative reinforcement and NAc dopaminergic transmission. In rats with postsurgical or neuropathic pain, blockade of opioid signaling in the rostral ACC (rACC) inhibited CPP and NAc dopamine release resulting from non-opioid pain-relieving treatments, including peripheral nerve block or spinal clonidine, an α2-adrenergic agonist. Conversely, pharmacological activation of rACC opioid receptors of injured, but not pain-free, animals was sufficient to stimulate dopamine release in the NAc and produce CPP. In neuropathic, but not sham-operated, rats, systemic doses of morphine that did not affect withdrawal thresholds elicited CPP and NAc dopamine release, effects that were prevented by blockade of ACC opioid receptors. The data provide a neural explanation for the preferential effects of opioids on pain affect and demonstrate that engagement of NAc dopaminergic transmission by non-opioid pain-relieving treatments depends on upstream ACC opioid circuits. Endogenous opioid signaling in the ACC appears to be both necessary and sufficient for relief of pain aversiveness.

Citing Articles

Intersect between brain mechanisms of conditioned threat, active avoidance, and reward.

Badarnee M, Wen Z, Hammoud M, Glimcher P, Cain C, Milad M Commun Psychol. 2025; 3(1):32.

PMID: 40011644 PMC: 11864974. DOI: 10.1038/s44271-025-00197-7.


Enhancing chronic low back pain management: an initial neuroimaging study of a mobile interoceptive attention training.

Strigo I, Garcia Guerra S, Torrisi S, Murphy E, Toor T, Goldman V Front Pain Res (Lausanne). 2024; 5:1408027.

PMID: 39403233 PMC: 11471628. DOI: 10.3389/fpain.2024.1408027.


Pregnancy ameliorates neuropathic pain through suppression of microglia and upregulation of the δ-opioid receptor in the anterior cingulate cortex in late-pregnant mice.

Sawada A, Yamakage M J Anesth. 2024; 38(6):828-838.

PMID: 39244720 DOI: 10.1007/s00540-024-03402-9.


Chronic morphine treatment induces sex- and synapse-specific cellular tolerance on thalamo-cortical mu opioid receptor signaling.

Jaeckel E, Arias-Hervert E, Perez-Medina A, Schulz S, Birdsong W J Neurophysiol. 2024; 132(3):968-978.

PMID: 39110512 PMC: 11427077. DOI: 10.1152/jn.00265.2024.


The 'in's and out's' of descending pain modulation from the rostral ventromedial medulla.

De Preter C, Heinricher M Trends Neurosci. 2024; 47(6):447-460.

PMID: 38749825 PMC: 11168876. DOI: 10.1016/j.tins.2024.04.006.


References
1.
Zubieta J, Stohler C . Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci. 2009; 1156:198-210. PMC: 3073412. DOI: 10.1111/j.1749-6632.2009.04424.x. View

2.
Kupers R, Konings H, Adriaensen H, Gybels J . Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain. 1991; 47(1):5-12. DOI: 10.1016/0304-3959(91)90004-H. View

3.
Cunningham C, Ferree N, Howard M . Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology (Berl). 2003; 170(4):409-22. DOI: 10.1007/s00213-003-1559-y. View

4.
Xu J, Brennan T . Comparison of skin incision vs. skin plus deep tissue incision on ongoing pain and spontaneous activity in dorsal horn neurons. Pain. 2009; 144(3):329-339. PMC: 2759309. DOI: 10.1016/j.pain.2009.05.019. View

5.
Okun A, DeFelice M, Eyde N, Ren J, Mercado R, King T . Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol Pain. 2011; 7:4. PMC: 3025866. DOI: 10.1186/1744-8069-7-4. View